NBIX vs NEE · P/E 45, rev $2.36B vs P/E 28, $153.16B cap
Neurocrine Biosciences Inc (NBIX) versus Nextera Energy Inc (NEE) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Nextera Energy Inc (NEE) is a utilities - regulated electric company listed on US.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
NEE does not have a complete income-statement cache yet.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. NEE currently screens at market cap $153.16B and trailing P/E 27.9.
Not investment advice. Open the NBIX and NEE stock pages for the full models.
Not investment advice.